18264364. METHODS FOR PREVENTING CARDIAC OR SKELETAL DEFECTS IN DISEASES INCLUDING MUCOPOLYSACCHARIDOSES simplified abstract (REGENTS OF THE UNIVERSITY OF MINNESOTA)

METHODS FOR PREVENTING CARDIAC OR SKELETAL DEFECTS IN DISEASES INCLUDING MUCOPOLYSACCHARIDOSES

Organization Name

REGENTS OF THE UNIVERSITY OF MINNESOTA

Inventor(s)

R. Scott Mcivor of St. Louis Park MN (US)

Nicholas Alexander Piers Sascha Buss of Rockville MD (US)

Troy C. Lund of Eden Prairie MN (US)

Elizabeth Braunlin of Roseville MN (US)

Lalitha R. Belur of St. Paul MN (US)

Carolyn Fairbanks of St. Paul MN (US)

Marie-Laure Nevoret of Virginia Beach VA (US)

METHODS FOR PREVENTING CARDIAC OR SKELETAL DEFECTS IN DISEASES INCLUDING MUCOPOLYSACCHARIDOSES - A simplified explanation of the abstract

This abstract first appeared for US patent application 18264364 titled 'METHODS FOR PREVENTING CARDIAC OR SKELETAL DEFECTS IN DISEASES INCLUDING MUCOPOLYSACCHARIDOSES

Simplified Explanation: This patent application provides a method to prevent, inhibit the progression of, reduce the severity of, or treat cardiac, vascular or skeletal dysfunction or defect(s) in a human with lysosomal storage disorder.

Key Features and Innovation:

• Method to address cardiac, vascular, or skeletal issues in individuals with lysosomal storage disorder.
• Potential to improve quality of life for patients with this condition.
• Innovative approach to treating associated dysfunctions.

Potential Applications: This technology could be applied in the medical field to improve the health outcomes of individuals with lysosomal storage disorder. It may also have implications for research into related conditions.

Problems Solved: This technology addresses the specific issues related to cardiac, vascular, and skeletal dysfunction in individuals with lysosomal storage disorder. By targeting these problems, it aims to improve overall health and well-being.

Benefits: The benefits of this technology include potentially reducing the severity of symptoms, inhibiting disease progression, and enhancing the quality of life for individuals with lysosomal storage disorder.

Commercial Applications: Title: Innovative Treatment for Cardiac, Vascular, and Skeletal Dysfunction in Lysosomal Storage Disorder Patients This technology could have commercial applications in the pharmaceutical industry for the development of new treatments for lysosomal storage disorders. It may also be of interest to healthcare providers looking to improve patient care in this area.

Prior Art: Readers interested in prior art related to this technology could start by exploring research on treatments for lysosomal storage disorders, as well as studies on cardiac, vascular, and skeletal dysfunction in these patients.

Frequently Updated Research: Researchers are continually exploring new ways to address the complex challenges associated with lysosomal storage disorders and their related complications. Stay informed on the latest advancements in this field to understand the evolving landscape of treatment options.

Questions about Cardiac, Vascular, and Skeletal Dysfunction in Lysosomal Storage Disorder Patients: 1. What are the current treatment options available for individuals with lysosomal storage disorder and associated cardiac, vascular, and skeletal dysfunction? 2. How does this technology compare to existing therapies for addressing these specific health issues in patients with lysosomal storage disorder?

Original Abstract Submitted

A method to prevent, inhibit the progression of, reduce the severity of, or treat cardiac, vascular or skeletal dysfunction or defect(s) in a human having lysosomal storage disorder, is provided.